To: Jack Rayfield who wrote (4276 ) 8/7/1999 12:55:00 PM From: AriKirA Read Replies (1) | Respond to of 8117
Hi Jack, I'll get back to you during the week with what I find Meanwhile, a form 41 was most probably filed with the BCSC STATEMENT OF EXECUTIVE COMPENSATION [....] A few definitions"replacement grant" of an option or SAR means the grant of an option or SAR reasonably related to any prior or potential cancellation of an option or SAR, whether by, (a) an exchange of existing options or SARs for options or SARs with new terms, (b) the grant of new options or SARs designed to operate in tandem with previously granted options or SARs that upon exercise will operate to cancel the previously granted options or SARs, (c) downward repricing of previously granted options or SARs, or (d) any other means; "repricing" of an option or SAR means the adjustment or amendment of the exercise or base price of an option or SAR previously awarded, whether through amendment, cancellation or replacement grants, or any other means, but does not include any repricing occurring through the operation of a formula or mechanism in, or applicable to, the previously awarded option or SAR that results in the periodic adjustment of the effective exercise, purchase or base price, a plan anti-dilution provision, or a recapitalization or similar transaction equally affecting all holders of the class of securities underlying the option or SAR and "repriced" has a corresponding meaning;M V Option and SAR Repricings V.1 If at any time after October 31, 1993 and during the most recently completed financial year, the issuer has repriced downward any options or freestanding SARs held by any Named Executive Officer, state the information specified in Subitem V.2 concerning all downward repricings of options or SARs held by executive officers of the issuer during the shorter of, (a) the 10 year period ending on the date of certification of the disclosure required by this Form, and (b) the period during which the issuer has been a reporting issuer, in the tabular form under the caption set out below. TABLE OF OPTION AND SAR REPRICINGS _____________________________________________________________________________________ Length of Market Original Price of Exercise Option Term Securities Under Securities at Price at Remaining at Options/SARs Time of Time of New Date of Date of Repriced or Repricing or Repricing or Exercise Repricing or Name Repricing Amended Amendment Amendment Price Amendment (#) ($/Security) ($/Security) ($/Security) (a) (b) (c) (d) (e) (f) (g) _____________________________________________________________________________________ _____________________________________________________________________________________ V.2 The table required by Subitem V.1 must include, for each downward repricing: (a) The name and position of the executive officer (column (a)). (b) The date of repricing (column (b)). (c) The number of securities underlying replacement or amended options or SARs (column (c)). (d) The per-security market price of the underlying security at the time of repricing (column (d)). (e) The original per-security exercise price or base price of the cancelled or amended option or SAR (column (e)). (f) The per-security exercise price or base price of the replacement option or SAR (column (f)), (g) The amount of time remaining before the replaced or amended option or SAR would have expired (column (g)). V.3 For the Table required by Subitem V.1: (a) Information about a replacement grant made during the financial year must be disclosed even if the corresponding original grant was cancelled in a prior year. (b) If the replacement grant is not made at the current market value, describe this fact and the terms of the grant in a footnote or accompanying textual narrative. (c) The information must be presented in groups according to issuer and class or series of security underlying options or SARs and within these groups in reverse chronological order. V.4 In a narrative immediately before or after the table required by this Item, explain in reasonable detail the basis for all downward repricings during the most recently completed financial year of options and SARs held by any of the Named Executive Officers.